Endocrinology

>

Latest News

Crinecerfontsafe, effective in treating children with congenital adrenal hyperplasia | Image Credit: © OpturaDesign - © OpturaDesign - stock.adobe.com.
Crinecerfont safe, effective in treating children with congenital adrenal hyperplasia

October 10th 2023

Crinecerfont, an investigational, oral, selective corticotropin-releasing factory type 1 receptor antagonist, achieved the primary and key secondary endpoints in a phase 3 study to treat congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children aged 2 to 17 years.

Girl testing glucose levels | Image Credit: © AntonioDiaz - © AntonioDiaz - stock.adobe.com.
Verapamil partially preserves beta cell function in children with newly diagnosed type 1 diabetes

March 31st 2023

FDA approves teplizumab for delay of type 1 diabetes in patients 8 years and up
FDA approves teplizumab for delay of type 1 diabetes in patients 8 years and up

November 18th 2022

Study finds children, young adults with down syndrome more likely to develop diabetes
Study finds children, young adults with down syndrome more likely to develop diabetes

October 17th 2022

Podcasts
Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Challenges in Diagnosis and Management for Patients with ADHD During the COVID-19 Pandemic

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Navigating a New Era of Food Allergy Management

Register Now!

FAQs in Peanut Allergy: Exploring Unanswered Questions Following Allergy Meeting Updates

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

View More

(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME

View More

Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations

View More

More News

© 2023 MJH Life Sciences

All rights reserved.